Diamedica Therapeutics Inc (DMAC)

May 22, 2026

DiaMedica Shareholders Approve Governance, Compensation and Incentive Plan - The Globe and Mail

May 22, 2026

May 21, 2026

DiaMedica Therapeutics (NASDAQ: DMAC) investors approve directors, pay and 3.5M-share incentive plan boost - Stock Titan

May 21, 2026

May 20, 2026

DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial - BioSpace

May 20, 2026

May 20, 2026

DiaMedica stroke trial reaches 75% of interim analysis threshold By Investing.com - Investing.com South Africa

May 20, 2026

May 20, 2026

DiaMedica stroke trial reaches 75% of interim analysis threshold - Investing.com India

May 20, 2026

May 20, 2026

DiaMedica Therapeutics (DMAC) Advances in Pivotal Trial Enrollme - GuruFocus

May 20, 2026

May 20, 2026

DiaMedica Therapeutics Says Trial of DM199 to Treat Acute Ischemic Stroke Reaches 75% Enrollment - marketscreener.com

May 20, 2026

May 19, 2026

Why Is DiaMedica Therapeutics Inc. (DMAC) Stock Down Today? - Meyka

May 19, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 13, 2026

DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference - BioSpace

May 13, 2026

May 10, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

May 10, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 09, 2026

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2026 Earnings Call Transcript - insidermonkey.com

May 09, 2026

May 09, 2026

DiaMedica (DMAC) Q1 2026 Earnings Transcript - AOL.com

May 09, 2026

May 08, 2026

Why DiaMedica (DMAC) deserves a deeper look right now (Bearish Sentiment) 2026-05-08Social Investment Platform - newser.com

May 08, 2026

May 08, 2026

DiaMedica Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2026

May 07, 2026

Transcript : DiaMedica Therapeutics Inc., Q1 2026 Earnings Call, May 07, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

DiaMedica Therapeutics Q1 Earnings Call Highlights - Barchart.com

May 07, 2026

May 07, 2026

DiaMedica Therapeutics Inc. Q1 2026 Financial Results, Clinical Trial Updates, and Forward-Looking Statements - Minichart

May 07, 2026

May 07, 2026

Earnings call transcript: DiaMedica Therapeutics Q1 2026 results show R&D focus - Investing.com

May 07, 2026

May 07, 2026

DMAC: DM199 trials progress in preeclampsia and stroke, with strong cash position and key data ahead - TradingView

May 07, 2026

May 07, 2026

Diamedica Therapeutics Inc. (DMAC) Files Form 8-K with Financial Statements and Company Information for May 2026 - Minichart

May 07, 2026

May 07, 2026

DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights - BioSpace

May 07, 2026

May 06, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Posts Wider Q1 Loss but Clinical Catalysts Fuel Stock Resilience - ChartMill

May 06, 2026

May 06, 2026

[10-Q] DiaMedica Therapeutics Inc. Quarterly Earnings Report - Stock Titan

May 06, 2026

May 06, 2026

DiaMedica Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 06, 2026

May 06, 2026

Higher R&D drives DiaMedica (NASDAQ: DMAC) wider Q1 2026 loss - Stock Titan

May 06, 2026

May 04, 2026

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review

May 03, 2026

May 02, 2026

DiaMedica Therapeutics (DMAC) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

May 02, 2026

Apr 30, 2026

DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026 - BioSpace

Apr 30, 2026

Apr 27, 2026

Top Wall Street forecasters revamp DiaMedica Therapeutics expectations ahead of Q4 earnings - MSN

Apr 27, 2026

Apr 24, 2026

DMAC Price Today: DiaMedica Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 23, 2026

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 23, 2026

Apr 23, 2026

DMAC DiaMedica Therapeutics Inc. reports narrower Q4 2025 loss than consensus forecasts, its stock rises modestly in today’s trading.Expert Market Insights - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

Is DiaMedica (DMAC) stock worth committing funds to (Drifts Higher) 2026-04-22Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026